News

The aim of the new collaboration is the research and development of small molecule inhibitors of oncogenic Ras for the treatment of cancer. Ras is the most frequently

Angiogenesis is correlated with disease progression and poor prognosis in many tumor types, such as colon, lung, breast and pancreatic cancers. Two key pathways, VEGF / VEGFR2 (KDR),

Incruse is a long-acting muscarinic antagonist (LAMA), a type of bronchodilator which can relax airway muscles and improve airflow in and out of the lungs. GSK Medical Director

The collaboration comes with the possibility of a one-year extension and will be focused on the development of new mRNA-based treatments and vaccines against four undisclosed viruses. As

The trial enrolled 73 children with mild to moderate atopic dermatitis into a four-week double-blind period, followed by a four-week open label extension for those patients who wish

Hanmi Pharmaceutical also will be making a strategic investment in Allegro that will advance and accelerate the global development program for Luminate. Under the terms of the agreements,

Actavis will immediately begin marketing approximately 20 injectable products across a number of therapeutic categories in the US. The Company will be a leader in Oncology, with nearly

"This new patent allowance is representative of our intellectual property strategy aimed at protecting and enhancing the value of VAL-083," stated Jeffrey Bacha, DelMar’s president and CEO. "This

As life expectancy rises worldwide, Alzheimer’s is becoming an increasingly lethal disease, placing enormous strain on caregivers and healthcare systems. With over 500,000 patients in Canada alone, the